Meggie Beckley, PA
Medical · Indianapolis, INNPI 1730343849
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $80,092 of the $124,527 with a category attached, or 64.3%. Medtronic accounts for 99.8% of it on its own, with 6 other manufacturers making up the rest. Among medical clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 436 payments — averaging $285.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$124K
- Revance Therapeutics, Inc.$134
- Merz North America, Inc.$69
- MML US, Inc.$22
- Tonix Medicines, Inc.$21
- Abbott$20
- plus $18 from 1 others
Across 1 payment — averaging $280.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$280
What the payments were for
- Speaking & faculty fees$80,09264%
- Travel & lodging$33,68827%
- Food & beverage$10,7029%
- Education$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 429 | $124,242 |
| Revance Therapeutics, Inc. | 1 | $134 |
| Merz North America, Inc. | 2 | $69 |
| MML US, Inc. | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $21 |
| Abbott | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$81,513
- INTELLIS ADAPTIVESTIM$20,619
- VANTA ADAPTIVESTIM$8,698
- SYNCHROMED$2,992
- RESTORESENSORSURESCAN$280
- OPTISPHERE$213
- SYNCRA CRT-P$190
- DAXXIFY$134
- Vanta$100
How this compares
$124,527 in reported general payments places this provider in the 95th percentile of 273 medical providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 55 | $1,563 |
| Gabapentin | 65 | $1,206 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 40 | $1,007 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $893 |
| Cyclobenzaprine Hcl | 27 | $563 |
| Tizanidine Hcl | 23 | $219 |
| Oxycodone Hcl | 12 | $205 |
| Tramadol Hcl | 11 | $119 |
| Meloxicam | 17 | $82 |
Paid to pharmacies, not to this prescriber.
Other medical in Indianapolis
- Jennifer ConnerIndianapolis$98K
- Jennifer IrwinIndianapolis$34K
- Andrew BurnsIndianapolis$13K
- Bridget WilliamsonIndianapolis$11K
- Lindsay MuellerIndianapolis$9K
- Meredith SlayterIndianapolis$8K
- Chelsea WilsonIndianapolis$5K
- Rachel SandersonIndianapolis$4K
- Ryan StromIndianapolis$4K
- Amanda EckhardtIndianapolis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.